JPH0698787A - Production of hyaluronic acid - Google Patents
Production of hyaluronic acidInfo
- Publication number
- JPH0698787A JPH0698787A JP25115592A JP25115592A JPH0698787A JP H0698787 A JPH0698787 A JP H0698787A JP 25115592 A JP25115592 A JP 25115592A JP 25115592 A JP25115592 A JP 25115592A JP H0698787 A JPH0698787 A JP H0698787A
- Authority
- JP
- Japan
- Prior art keywords
- culture
- hyaluronic acid
- consumption rate
- oxygen consumption
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 32
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 32
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- 230000036284 oxygen consumption Effects 0.000 claims abstract description 37
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000001301 oxygen Substances 0.000 claims abstract description 19
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 19
- 239000007789 gas Substances 0.000 claims abstract description 17
- 244000005700 microbiome Species 0.000 claims abstract description 14
- 238000005273 aeration Methods 0.000 claims abstract description 12
- 241000194017 Streptococcus Species 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 abstract description 20
- 238000012258 culturing Methods 0.000 abstract description 8
- 230000002572 peristaltic effect Effects 0.000 abstract description 7
- 239000001963 growth medium Substances 0.000 abstract description 5
- 241000120569 Streptococcus equi subsp. zooepidemicus Species 0.000 abstract description 4
- 238000013019 agitation Methods 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 150000004676 glycans Chemical class 0.000 abstract description 3
- 229920001282 polysaccharide Polymers 0.000 abstract description 3
- 239000005017 polysaccharide Substances 0.000 abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 38
- 239000012526 feed medium Substances 0.000 description 22
- 229910052757 nitrogen Inorganic materials 0.000 description 21
- 229940041514 candida albicans extract Drugs 0.000 description 14
- 239000012138 yeast extract Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 239000001888 Peptone Substances 0.000 description 11
- 108010080698 Peptones Proteins 0.000 description 11
- 235000019319 peptone Nutrition 0.000 description 11
- 239000000203 mixture Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 150000002829 nitrogen Chemical class 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 229940075397 calomel Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 230000033116 oxidation-reduction process Effects 0.000 description 2
- -1 polypeptone Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、微生物によるヒアルロ
ン酸の安定的な製造法に関する。TECHNICAL FIELD The present invention relates to a stable method for producing hyaluronic acid by a microorganism.
【0002】[0002]
【従来の技術】ヒアルロン酸は分子量が数百万の多糖類
の一種であり、生体内の、例えば、硝子体・皮膚・関節
液などに含まれ、水分の保持、潤滑剤的な役割、細菌類
の侵入防止などに役立っている。近年、化粧品、医薬品
(関節炎治療薬・眼薬・創傷治癒剤)等に用途の拡大が
期待されている。2. Description of the Related Art Hyaluronic acid is a type of polysaccharide having a molecular weight of several millions, and is contained in the living body, for example, in the vitreous body, skin, joint fluid, etc., and retains water, functions as a lubricant, and bacteria. It is useful for prevention of invasion of other kinds. In recent years, it is expected that the applications will be expanded to cosmetics, pharmaceuticals (arthritis remedies, eye drops, wound healing agents) and the like.
【0003】ヒアルロン酸の製造法は、当初、極めて高
価な、生体組織からの抽出を出発として、微生物による
培養生産法へと鋭意研究が進められている。微生物によ
る培養生産法としては、ストレプトコッカス属のヒアル
ロン酸生産菌をグルコース3%以上の培地で通気攪拌培
養する方法(特開昭58−56692号)、培養液中の
酸化還元電位を−100〜−400mVになるよう通気
攪拌培養する方法(特開昭62−51999号)、培養
液粘度を100〜800センチポイズに制御する方法
(特開昭63−94988号)、およびヒアルロニダー
ゼ非生産変異株を使用する方法(特開平1−67196
号)等が公開されている。Initially, the method for producing hyaluronic acid has been intensively studied as a culture production method using a microorganism, starting from the extraction of living tissue, which is extremely expensive. As a method for culturing and producing by a microorganism, a method of agitating a hyaluronic acid-producing bacterium of the genus Streptococcus in a medium containing 3% or more of glucose by aeration and stirring (Japanese Patent Laid-Open No. 58-56692), the oxidation-reduction potential of the culture solution is -100 to- A method of aerating and agitating to 400 mV (Japanese Patent Laid-Open No. 62-51999), a method of controlling the culture solution viscosity to 100 to 800 centipoise (Japanese Patent Laid-Open No. 63-94988), and a hyaluronidase non-producing mutant strain are used. Method (JP-A-1-67196
No.) etc. have been published.
【0004】ヒアルロン酸の生産は、通常、通気攪拌培
養条件下で行っているが、特に、上記文献のなかで、通
気、即ち酸素の供給に関連するものとしては、培養液中
の酸化還元電位を−100〜−400mVになるよう通
気攪拌培養する方法(特開昭62−51999号)が挙
げられる。この方法においては、培養液中の酸化還元電
位を白金−カロメル電極等の液中センサーにより直接測
定するものであった。The production of hyaluronic acid is usually carried out under aeration and agitation culture conditions. Particularly, in the above-mentioned literature, the one related to aeration, that is, supply of oxygen, is a redox potential in a culture solution. The method of culturing with aeration and agitation at -100 to -400 mV (Japanese Patent Laid-Open No. 62-51999) can be mentioned. In this method, the redox potential in the culture solution was directly measured by a submerged sensor such as a platinum-calomel electrode.
【0005】[0005]
【発明が解決しようとする課題】本発明者らは、常法的
なバッチ培養法にて、上記文献の通り、培養液中の酸化
還元電位を白金−カロメル電極の液中センサーにより直
接測定し、好ましいとされる−100〜−400mVに
なるよう通気攪拌制御してヒアルロン酸の製造を行った
ところ、この方法においては、収量の多いときと収量の
少ないときがバラバラであり、工業的生産としては極め
て不安定な方法であると判断された。また上記の種々の
公知技術にしたがっても、前記と同様に、安定的かつ高
収量な生産は達成できず、ヒアルロン酸を安定的かつ高
収量に生産できる新たな製造法の開発が待たれていた。DISCLOSURE OF THE INVENTION The inventors of the present invention directly measure the oxidation-reduction potential in a culture solution by a conventional batch culture method using a platinum-calomel electrode submerged sensor as described above. When a hyaluronic acid was produced by controlling aeration and stirring so that the preferable amount would be −100 to −400 mV, in this method, a high yield and a low yield were dissimilar. Was determined to be an extremely unstable method. Further, even in accordance with the above-mentioned various known techniques, similarly to the above, stable and high-yield production cannot be achieved, and development of a new production method capable of producing hyaluronic acid stably and in high-yield has been awaited. .
【0006】[0006]
【課題を解決するための手段】本発明者らは、上記課題
を解決すべく鋭意研究した結果、ヒアルロン酸自体が高
分子高粘性物質である為に、その生成にしたがって粘度
が上昇し、最終的には、培養液は5,000〜15,0
00センチポアズと著しく高粘性となり、高粘性である
が故に不均一な系となって、液中センサーによるフィー
ドバック制御は不確実で、安定した生産を実施する事が
困難であることを見出し、新たな製造法の確立をするに
至った。Means for Solving the Problems As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that hyaluronic acid itself is a highly viscous high-molecular substance, so that its viscosity increases as it is produced, and Specifically, the culture medium is 5,000 to 15,000.
It became extremely viscous as 00 centipoise, and because it was highly viscous, it became a non-uniform system, and feedback control by the submerged sensor was uncertain, and it was difficult to carry out stable production. We have established a manufacturing method.
【0007】即ち、本発明は、ストレプトコッカス属に
属するヒアルロン酸を生成する能力を有する微生物を通
気攪拌培養するに際し、培養槽のガス供給口とガス排気
口の酸素含量を測定し、該微生物の酸素消費速度を5〜
8 m mol 02 /L・hr.に制御することを特
徴とするヒアルロン酸の製造法である。以下に本発明を
詳細に説明する。That is, according to the present invention, when a microorganism belonging to the genus Streptococcus and capable of producing hyaluronic acid is subjected to aeration and stirring culture, the oxygen content of the gas supply port and the gas exhaust port of the culture tank is measured to determine the oxygen content of the microorganism. 5 to consumption speed
8 m mol 0 2 / L · hr. It is a method for producing hyaluronic acid, which is characterized in that The present invention will be described in detail below.
【0008】本発明に使用する微生物は、ヒアルロン酸
を菌体外に蓄積する菌株であれば何れも使用可能である
が、特にストレプトコッカス属細菌の中のランスフィー
ド(Lancefield )による血清学的分類[バ
ージーズ・マニュアル・オブ・デタミネィティブ・バク
テリオロジィ(Bergey’s Manual of
Determinative Bacterio
l.)491,1974]のC群の菌株が望ましい。具
体的な例としてはストレプトコッカス・エキ、ストレプ
トコッカス・エキシミリス、ストレプトコッカス・ディ
スガラクチィエ、ストレプトコッカス・ズーエピデミカ
スなどが挙げられる。特に好適にはストレプトコッカス
・ズーエピデミカス NCTC7023,NCTC69
63,NCTC7022等が挙げられる。これらの菌株
は、βー溶血性は僅かに陽性であり又ヒアルロニダーゼ
は非生産性である[ジャーナル・オブ・ジェネラル・ミ
クロバイオロジィ(J.Gen.Microbiol.
15,485〜,1956)]。As the microorganism used in the present invention, any strain can be used as long as it is a strain that accumulates hyaluronic acid outside the cells. In particular, serological classification by Lancefield among Streptococcus bacteria [ Bergey's Manual of Determinating Bacteriology (Bergey's Manual of)
Determinative Bacterio
l. ) 491, 1974] group C strains are preferred. Specific examples thereof include Streptococcus equi, Streptococcus excimilis, Streptococcus disgalactiae, Streptococcus zooepidemicus and the like. Particularly preferably Streptococcus zooepidemicus NCTC7023, NCTC69
63, NCTC7022 and the like. These strains are slightly positive for β-hemolysis and non-productive for hyaluronidase [J. Gen. Microbiol.
15, 485, 1956)].
【0009】本発明で酸素消費速度とは、酸素の供給量
と使用されなかった量の差より求められる酸素消費量
を、単位時間、単位液量当りに換算したものである。本
発明において酸素消費速度を測定するには、培養槽のガ
ス供給口とガス排気口の酸素含量を測定することによ
り、培養槽全体の酸素消費量を求め、単位時間、単位液
量当りに換算した酸素消費速度を算出すればよい。In the present invention, the oxygen consumption rate is the oxygen consumption calculated from the difference between the amount of oxygen supplied and the amount not used, converted into unit time and unit liquid amount. To measure the oxygen consumption rate in the present invention, the oxygen content of the entire culture tank is obtained by measuring the oxygen content at the gas supply port and the gas exhaust port of the culture tank, and converted into unit time and unit liquid volume. The oxygen consumption rate may be calculated.
【0010】培養槽のガス供給口とガス排気口の酸素含
量の測定は、感度の高い測定法で行う必要があり、好ま
しくは、質量分析計にて実施することができる。本発明
で酸素含量を測定するに際しては、通常は、ガス供給口
とガス排気口のそれぞれで測定することが好ましいが、
酸素の供給量が予めわかっている場合、例えば酸素の供
給速度が一定にコントロールされていれば、ガス排気口
の酸素含量のみを測定することで酸素消費速度の算出は
可能である。The oxygen content at the gas supply port and the gas exhaust port of the culture tank must be measured by a highly sensitive measuring method, and preferably, it can be carried out by a mass spectrometer. When measuring the oxygen content in the present invention, usually, it is preferable to measure at each of the gas supply port and the gas exhaust port,
When the oxygen supply rate is known in advance, for example, if the oxygen supply rate is controlled to be constant, the oxygen consumption rate can be calculated by measuring only the oxygen content at the gas exhaust port.
【0011】供給ガスは、酸素を含み、微生物の培養に
悪影響を及ぼさない気体であれば特に限定されないが、
通常は空気を用いればよい。また、酸素ガスを単独で使
用してもよいが、空気、二酸化炭素や窒素等により適宜
酸素濃度を調節することも好ましい。供給ガスにおける
酸素濃度は、一定としても変動させてもよいが、通常は
一定とすることが制御の上で好ましい。The supply gas is not particularly limited as long as it contains oxygen and does not adversely affect the culture of microorganisms.
Normally, air may be used. Although oxygen gas may be used alone, it is also preferable to appropriately adjust the oxygen concentration with air, carbon dioxide, nitrogen or the like. The oxygen concentration in the supply gas may be constant or may vary, but normally it is preferable to keep it constant for control purposes.
【0012】斯くして測定された酸素消費速度が、5〜
8 m mol 02 /L・hr.から外れた場合に
は、好ましくは、窒素源を加減することにより簡単に制
御できる。例えば、酸素消費速度が上記範囲より低い数
値となった場合には、培地中に窒素源を追加すればよ
く、この範囲より高い数値となった場合には、窒素源の
追加を減ずるか停止すればよい。時には、さらに希釈等
の手段により酸素消費速度を下げることもできるが、通
常は培養開始時の培養組成における窒素源を制限し、適
宜窒素源を添加する方法が好ましい。酸素消費速度を上
昇させるために添加する窒素源の量は、使用する菌株や
培養条件等により異なるので、リアルタイムに測定した
酸素消費速度を指標に窒素源の添加量を調節するシステ
ム、例えば、窒素源をペリスタポンプ等のポンプで連続
的に添加する方法において、酸素消費速度により自動的
にポンプの停止、再開、あるいは供給速度の増減によっ
て、容易に実施できる。添加方法は、連続的または断続
的に行ってもよい。また、その他の酸素消費速度の制御
方法としては、水やその他の栄養源の供給量や酸素供給
量等によることも可能であるが、微妙なコントロールが
比較的難しいことが多いので、上述の窒素源の添加との
組み合わせでコントロールすることも好ましい。The oxygen consumption rate thus measured is 5 to
8 m mol 0 2 / L · hr. If it is out of the range, it can be easily controlled by adjusting the nitrogen source. For example, if the oxygen consumption rate is lower than the above range, a nitrogen source may be added to the medium.If the oxygen consumption rate is higher than this range, the addition of nitrogen source should be reduced or stopped. Good. At times, the rate of oxygen consumption can be further reduced by means such as dilution, but a method of limiting the nitrogen source in the culture composition at the start of the culture and adding a nitrogen source appropriately is usually preferable. The amount of nitrogen source added to increase the oxygen consumption rate varies depending on the strain used, culture conditions, etc., so a system for adjusting the addition amount of the nitrogen source using the oxygen consumption rate measured in real time as an index, for example, nitrogen. The method of continuously adding the source with a pump such as a peristaltic pump can be easily performed by automatically stopping or restarting the pump or increasing or decreasing the supply rate according to the oxygen consumption rate. The addition method may be performed continuously or intermittently. Further, as a method of controlling the oxygen consumption rate other than the above, it is possible to use the supply amount of water or other nutrient sources or the oxygen supply amount, but since the delicate control is often relatively difficult, It is also preferable to control in combination with addition of a source.
【0013】上述の窒素源とは、微生物に資化される窒
素源であれば特に限定されないが、有機態の窒素源が好
ましい。またこの窒素源は、水溶性であることが好まし
いが、結果的には資化されて水溶性となる窒素源であれ
ば用いることができる。この窒素源としては、例えば、
ペプトン、ポリペプトン、酵母エキス、粉末酵母、コー
ンスチープリカー、肉エキス等が例示され、特に好まし
くはペプトンまたは酵母エキスが挙げられる。この窒素
源には、その他の栄養源が適宜添加されていてもよい。
窒素源は、通常水溶液または懸濁液にて添加すればよ
く、その濃度は、余りに薄い場合には培養液を希釈し効
率的に好ましくなく、また余りに濃い場合には、ポンプ
等により調節することのできる最小量の添加にて過剰と
なり、実際的に調節ができないので好ましくない。この
濃度は、供給する期間において、一定であっても変動さ
せてもよいが、通常は一定とすることが好ましい。この
濃度は、窒素源や条件により異なるが、通常ペプトンで
1〜20%程度、イーストエキスで1〜15%程度が例
示される。The above-mentioned nitrogen source is not particularly limited as long as it is a nitrogen source that is assimilated by microorganisms, but an organic nitrogen source is preferable. Further, this nitrogen source is preferably water-soluble, but any nitrogen source which is eventually assimilated to be water-soluble can be used. As this nitrogen source, for example,
Examples thereof include peptone, polypeptone, yeast extract, powdered yeast, corn steep liquor, meat extract, and the like, and particularly preferable examples include peptone or yeast extract. Other nutrient sources may be appropriately added to this nitrogen source.
The nitrogen source may be added usually in the form of an aqueous solution or suspension, and its concentration is not preferable because it dilutes the culture solution when it is too thin, and when it is too thick, it should be adjusted with a pump or the like. It is not preferable because the addition of the minimum amount that can be added causes excess and cannot be adjusted practically. This concentration may be constant or varied during the supply period, but it is usually preferable to keep it constant. This concentration varies depending on the nitrogen source and conditions, but is usually about 1 to 20% for peptone and about 1 to 15% for yeast extract.
【0014】培養開始時の培養組成としては、通常に用
いられる炭素源、窒素源、塩類やビタミン類等が使用で
きる。具体的には、炭素源としてグルコース、シューク
ロース、澱粉加水分解物等が挙げられるが、特に生産性
においてシュークロースが好ましい。又窒素源として前
述の通りであり、ペプトン、酵母エキス、コーンスチー
プリカー、肉エキスなどの有機態窒素源の添加が望まし
く、硫酸アンモニウム、塩化アンモニウム、硝酸アンモ
ニウムなどを併用する事も出来る。又この他に、塩化ナ
トリウム或いはマグネシウム、カリウム、鉄、カルシウ
ム等のリン酸塩、硫酸塩、炭酸塩等及び微量のビタミン
類が必要に応じて添加される。また、消泡剤等の使用も
適宜行うことができる。As the culture composition at the start of the culture, carbon sources, nitrogen sources, salts, vitamins and the like which are commonly used can be used. Specific examples of the carbon source include glucose, sucrose, and starch hydrolysates, and sucrose is particularly preferable in terms of productivity. The nitrogen source is as described above, and it is desirable to add an organic nitrogen source such as peptone, yeast extract, corn steep liquor and meat extract, and ammonium sulfate, ammonium chloride, ammonium nitrate and the like can be used together. In addition to these, phosphates such as sodium chloride or magnesium, potassium, iron, calcium, etc., sulfates, carbonates, etc. and trace amounts of vitamins are added as necessary. Moreover, the use of an antifoaming agent or the like can be appropriately performed.
【0015】ヒアルロン酸生産微生物は、培養条件等に
より異なるが、例えば通常、培養後約10時間前後程度
までにその菌体の増殖期があり、以後ヒアルロン酸の主
な生産時期が続くパターンが多い。本発明において酸素
消費速度の制御は、実質的なヒアルロン酸の生産時期に
制御されていればよく、菌体の増殖期の酸素消費速度の
制御は必ずしも必要とされるものではない。増殖初期に
は当然に酸素消費速度が極めて低いし、他の条件を変動
させない限り培養開始時の培養組成によっては、極めて
高い酸素消費速度の増大を示し、一旦は酸素消費速度が
5〜8 m mol 02 /L・hr.の範囲を越える
こともあり得るが、本発明においてはその後の実質的な
ヒアルロン酸の生産時期に酸素消費速度が前記範囲に制
御されていればよい。しかしながら、培養開始時の培養
組成が多すぎると、実質的なヒアルロン酸の生産時期に
なっても酸素消費速度が前記範囲まで下がらず、制御し
にくい場合も多くなるので、通常、培養開始時の培養組
成は、実質的なヒアルロン酸の生産時期には、前記範囲
までに下がり得る含量を選択することが好ましい。この
適当な培養開始時の培養組成を選択するには、菌株や培
養条件により異なるので、予備的にバッチ培養をしてそ
の酸素消費速度の変動を測定すれば容易に選択できる。
また、酸素消費速度を一旦高め、下がる頃合を見計らっ
て新たな窒素源を添加することは、その低下が急激であ
ることが多いことから、酸素消費速度の制御が比較的難
しく、予め使用するヒアルロン酸の生産時期に急激に低
下する場合が多いので、結果的にヒアルロン酸の生産時
期に酸素消費速度を前記範囲に制御することが比較的難
しく、増殖期の終期においても酸素消費速度が前記範囲
以内となる程度に培養開始時の培養組成の窒素源を予め
制限しておき、徐々に添加を開始することがより好まし
い。[0015] The hyaluronic acid-producing microorganisms vary depending on the culture conditions and the like, but, for example, usually there is a growth phase of the cells by about 10 hours after culturing, and there are many patterns in which the main production period of hyaluronic acid continues thereafter. . In the present invention, the oxygen consumption rate may be controlled substantially at the production period of hyaluronic acid, and the oxygen consumption rate during the growth period of the bacterial cells is not necessarily required to be controlled. Obviously, the oxygen consumption rate is extremely low in the early stage of growth, and unless the other conditions are changed, depending on the culture composition at the start of the culture, an extremely high oxygen consumption rate increases, and once the oxygen consumption rate is 5 to 8 m. mol 0 2 / L · hr. However, in the present invention, it is sufficient that the oxygen consumption rate is controlled within the above range during the subsequent substantial production period of hyaluronic acid. However, if the culture composition at the start of culturing is too large, the oxygen consumption rate does not fall to the above range even at the time of substantial production of hyaluronic acid, and there are many cases where it is difficult to control. Regarding the culture composition, it is preferable to select a content that can be lowered to the above range at the time of substantial production of hyaluronic acid. The selection of the appropriate culture composition at the start of culture varies depending on the strain and culture conditions, and therefore can be easily selected by preliminary batch culture and measuring the fluctuation of the oxygen consumption rate.
In addition, it is relatively difficult to control the oxygen consumption rate when adding a new nitrogen source in anticipation of when the oxygen consumption rate is once lowered and when it falls, and it is relatively difficult to control the oxygen consumption rate beforehand. Since it often decreases sharply during the production period of acid, it is relatively difficult to control the oxygen consumption rate within the above range during the production period of hyaluronic acid, and the oxygen consumption rate falls within the above range even at the end of the growth phase. It is more preferable to limit the nitrogen source of the culture composition at the start of the culture in advance to such an extent that it is within the range, and then gradually start the addition.
【0016】培養は、通気攪拌の好気的条件下で実施さ
れ、通気条件は攪拌とともに考慮されなければならない
が、通常0.2〜2.0vvm程度が例示され、撹拌条
件は、培養液の粘性や培養槽の大きさ等により適宜選択
すればよい。培養温度は通常25〜42℃、好ましくは
37゜C前後が挙げられ、pHは通常は6〜8程度にコ
ントロールされ、通常1〜2日間の培養でヒアルロン酸
が生産される。通常ヒアルロン酸は主として菌体外に蓄
積する。The culture is carried out under aerobic conditions such as aeration and stirring, and the aeration conditions should be considered together with the stirring, but usually about 0.2 to 2.0 vvm is exemplified, and the stirring conditions include the culture medium. It may be appropriately selected depending on the viscosity and the size of the culture tank. The culture temperature is usually 25 to 42 ° C., preferably around 37 ° C., the pH is usually controlled to about 6 to 8, and hyaluronic acid is usually produced by culturing for 1 to 2 days. Usually, hyaluronic acid mainly accumulates outside the cells.
【0017】培養液からのヒアルロン酸の分離精製する
場合には、例えば、先ず培養終了後培養液を60゜C、
30分加熱処理してβー溶血性物質を分解し、次に水で
希釈してその粘度を100センチポアズ以下に下げ、濾
過助剤を添加後遠心分離又は濾過により菌体を除去し、
上清液から従来公知の多糖の分離精製法即ち、限外濾
過、透析、イオン交換樹脂、有機溶媒沈殿法等を用いて
精製し、凍結乾燥、真空濾過、噴霧乾燥などの手段を用
いてヒアルロン酸を得る事が出来る。In the case of separating and purifying hyaluronic acid from the culture solution, for example, first, after the culture is completed, the culture solution is kept at 60 ° C.
Heat treatment for 30 minutes to decompose β-hemolytic substance, then dilute with water to reduce its viscosity to 100 centipoise or less, add a filter aid and remove cells by centrifugation or filtration,
It is purified from the supernatant using a conventionally known method for separating and purifying polysaccharides, that is, ultrafiltration, dialysis, an ion exchange resin, an organic solvent precipitation method, etc., and hyaluron is used by means such as freeze-drying, vacuum filtration and spray drying. You can get acid.
【0018】[0018]
【実施例】次に実施例により本発明をさらに詳細に説明
するが、本発明はこれらの例によってなんら限定される
ものではない。EXAMPLES The present invention will be described in more detail by way of examples, which should not be construed as limiting the invention thereto.
【0019】[0019]
【実施例1】グルコース(日本資糧工業社製)1.0
%、ペプトン(極東製薬社製)1.5%、イーストエキ
ス(極東製薬社製)0.5%、CaC03 (白石社製)
0.2%を含む培地1Lを2L容三角フラスコに入れて
オートクレーブ殺菌した培地に、凍結乾燥保存されてい
るストレプトコッカス・ズーエピデミカス NCTC7
023を植え付け、37゜C、25時間静置培養を行な
い種培養とした。[Example 1] Glucose (manufactured by Nippon Sanyo Kogyo Co., Ltd.) 1.0
%, Peptone (Far East Pharmaceutical Co., Ltd.) 1.5%, (manufactured by Far East Pharmaceutical Co., Ltd.) yeast extract 0.5% (manufactured by Shiraishi, Inc.) CaC0 3
Streptococcus zooepidemicus NCTC7 lyophilized and preserved in a medium sterilized by autoclaving 1 L of a medium containing 0.2% in a 2 L Erlenmeyer flask.
023 was inoculated, and static culture was performed at 37 ° C. for 25 hours to obtain a seed culture.
【0020】主培養は、30L容ジャーファーメンター
でペプトン0.4%,イーストエキス0.3%,BC−
51Y(日本油脂社製、消泡剤)0.05%を殺菌した
ものに、別のオートクレーブで殺菌したシュークロース
(三井製糖社製)6%を添加し18Lとして、上記種培
養を0.04%植菌して、37゜Cで、通気は1vv
m、攪拌は200rpmより粘度上昇にしたがって増加
させ充分撹拌し、12NのNaOHでpH7.0〜7.
2にコントロールし、24時間培養した。The main culture was a 30 L jar fermenter with 0.4% peptone, 0.3% yeast extract and BC-
51% (Nippon Yushi Co., defoaming agent) 0.05% was sterilized, and 6% of sucrose (manufactured by Mitsui Sugar Co., Ltd.) sterilized by another autoclave was added to 18 L to make the seed culture 0.04. % Inoculation, aeration of 1vv at 37 ° C
m, stirring was increased from 200 rpm as the viscosity increased and sufficiently stirred, and the pH was adjusted to 7.0 to 7.
It was controlled to 2 and cultured for 24 hours.
【0021】ペプトン8.4%、イーストエキス4.9
%を含有した混合液をフィード培地とした。質量分析計
(ウエストロン社製、WSMR型)にて、供給口および
排気口のそれぞれの酸素含量を測定しその測定値から算
出された酸素消費速度が5〜8 m mol 02 /L
・hr.の範囲になるように、主培養開始後10時間目
から、該フィード培地をペリスタポンプにより添加速度
を自動調整しながら、連続的にジャーファーメンターへ
フィードした。主培養開始後24時間でフィード培地を
約2L添加し、培養を終了した。Peptone 8.4%, yeast extract 4.9
The mixed solution containing 100% was used as the feed medium. The oxygen content of each of the supply port and the exhaust port was measured with a mass spectrometer (WSMR type, manufactured by Westlon Co., Ltd.), and the oxygen consumption rate calculated from the measured values was 5 to 8 mmol mol 0 2 / L.
-Hr. From the 10th hour after the start of the main culture, the feed medium was continuously fed to the jar fermenter while the addition rate was automatically adjusted by a peristaltic pump so as to fall within the range. About 24 hours after the start of the main culture, about 2 L of the feed medium was added to complete the culture.
【0022】培養液の一部(2.75L)を60゜C、
30分間熱処理を行ない、水4Lを加えて希釈し、次に
塩酸でpH4に修正し、濾過助剤パーライト50gを加
え、ヌッツェで濾過した。濾過されたケーキを水で洗浄
し、得られた濾液と洗液を合わせて7.1Lを得た。こ
の液に塩化ナトリウム44gを溶解し、次にアセトン8
Lを添加し、ヒアルロン酸を沈殿分別させた。この沈殿
を濾取し、0.5モル塩化ナトリウム溶液5Lに溶解
し、エタノール10Lを加え、生じた沈澱を濾取し、こ
の沈澱を75%エタノール水、ついでエタノールで充分
洗浄後、真空乾燥して19.8gのヒアルロン酸を得
た。培養液1L当り7.2gの生産量で、この物の分子
量は約170万(粘度法)であった。A portion (2.75 L) of the culture solution was added at 60 ° C,
After heat treatment for 30 minutes, 4 L of water was added to dilute, the pH was adjusted to 4 with hydrochloric acid, 50 g of filter aid perlite was added, and the mixture was filtered through Nutze. The filtered cake was washed with water, and the obtained filtrate and washings were combined to obtain 7.1L. Sodium chloride (44 g) was dissolved in this solution, and then acetone (8 g) was added.
L was added, and hyaluronic acid was separated by precipitation. This precipitate was collected by filtration, dissolved in 5 L of 0.5 molar sodium chloride solution, 10 L of ethanol was added, the precipitate formed was collected by filtration, and the precipitate was thoroughly washed with 75% ethanol water and then with ethanol, and then dried in vacuum. To obtain 19.8 g of hyaluronic acid. The production amount of 7.2 g per liter of the culture broth was about 1.7 million (viscosity method).
【0023】[0023]
【比較例1】実施例1のフィード培地を、ペプトン2.
4%とイーストエキス1.4%を含有したペプトン・イ
ーストエキスの混合液からなるフィード培地と代え、酸
素消費速度が1〜4 m mol 02 /L・hr.の
範囲になるように制御して培養した。主培養開始後24
時間でフィード培地を約2L添加し、培養を終了した。
その結果、ヒアルロン酸の収量は実施例1に比較して極
めて少なかった。Comparative Example 1 The feed medium of Example 1 was mixed with peptone 2.
Instead of a feed medium consisting of a mixed solution of peptone-yeast extract containing 4% of yeast extract and 1.4% of yeast extract, the oxygen consumption rate was 1 to 4 mmol mol 0 2 / L · hr. The culture was carried out by controlling so as to be within the range. 24 after the start of main culture
About 2 L of feed medium was added over time to complete the culture.
As a result, the yield of hyaluronic acid was extremely low as compared with Example 1.
【0024】[0024]
【比較例2】実施例1のフィード培地を、ペプトン1
4.4%とイーストエキス8.4%を含有したペプトン
・イーストエキスの混合液からなるフィード培地と代
え、その他は実施例1の方法と同様に行った。主培養開
始後24時間でフィード培地を約2L添加し、培養を終
了した。その結果、ヒアルロン酸の収量は実施例1に比
較して少なかった。Comparative Example 2 The feed medium of Example 1 was mixed with peptone 1
The same procedure as in Example 1 was carried out except that the feed medium was replaced by a feed medium consisting of a mixed solution of peptone-yeast extract containing 4.4% and 8.4% yeast extract. About 24 hours after the start of the main culture, about 2 L of the feed medium was added to complete the culture. As a result, the yield of hyaluronic acid was lower than that in Example 1.
【0025】[0025]
【実施例2】実施例1と同様の方法で、5回繰り返して
培養した結果、培養液1L当たりの収量は、其々、7.
2g、7.5g、7.0g、7.1g、7.3gとな
り、その平均値は7.2g/L、変動係数2.7であり
非常に安定した生産性を示した。Example 2 As a result of repeating the culture 5 times in the same manner as in Example 1, the yield per 1 L of the culture solution was 7.
The amounts were 2 g, 7.5 g, 7.0 g, 7.1 g, and 7.3 g, and the average values were 7.2 g / L and the coefficient of variation was 2.7, showing extremely stable productivity.
【0026】[0026]
【比較例3】実施例1の主培養培地のうち、ペプトンお
よびイーストエキスのみを、其々1.2%及び0.7%
とし、培養途中において新たな栄養源をフィードせず、
全く酸素消費速度も制御せずに培養した。酸素消費速度
は約10時間目に約19になり、その後急激に減少し1
〜4の値を示した。5回の培養において、培養液1L当
たりの収量は、其々、5.6g、5.3g、7.5g、
4.5g、4.8g、5.7gとなり、その平均値は
6.1g/L、変動係数21.2であり不安定な生産性
を示した。Comparative Example 3 Of the main culture medium of Example 1, only peptone and yeast extract were added at 1.2% and 0.7%, respectively.
In the middle of culturing, no new nutrient source is fed,
The culture was performed without controlling the oxygen consumption rate at all. The oxygen consumption rate reaches about 19 at about 10 hours, and then decreases sharply 1
Values of ~ 4 were shown. The yield per 1 L of the culture solution after culturing 5 times was 5.6 g, 5.3 g, 7.5 g, and
The amounts were 4.5 g, 4.8 g and 5.7 g, the average value was 6.1 g / L, and the variation coefficient was 21.2.
【0027】[0027]
【実施例3】実施例1のフィード培地を、ペプトン12
%水溶液に置き換えて、実施例1と同様に酸素消費速度
を5〜8 m mol 02 /L・hr.の範囲になる
ように、主培養開始後10時間目から、該フィード培地
をペリスタポンプにより添加速度を自動調整し培養を行
った。主培養開始後24時間でフィード培地を約2L添
加し、培養を終了した。培養液1L当たりの収量は、平
均7.4g/Lであり、また5回の変動係数も小さく非
常に安定した生産性を示した。Example 3 The feed medium of Example 1 was mixed with peptone 12
% Aqueous solution, and the oxygen consumption rate was 5 to 8 mmol mol 0 2 / L · hr. From the 10th hour after the start of the main culture, the rate of addition of the feed medium was automatically adjusted by a peristaltic pump so as to be within the range. About 24 hours after the start of the main culture, about 2 L of the feed medium was added to complete the culture. The yield per liter of culture broth was 7.4 g / L on average, and the coefficient of variation of 5 times was small, showing very stable productivity.
【0028】[0028]
【実施例4】実施例1のフィード培地を、イーストエキ
ス7%水溶液に置き換えて、実施例1と同様に酸素消費
速度を5〜8 m mol 02 /L・hr.の範囲に
なるように、主培養開始後10時間目から、該フィード
培地をペリスタポンプにより添加速度を自動調整し培養
を行った。主培養開始後24時間でフィード培地を約2
L添加し、培養を終了した。培養液1L当たりの収量
は、平均7.2g/Lであり、また5回の変動係数も小
さく非常に安定した生産性を示した。[Example 4] The feed medium of Example 1 was replaced with a 7% aqueous solution of yeast extract, and the oxygen consumption rate was 5 to 8 mmol mol 0 2 / L · hr. From the 10th hour after the start of the main culture, the rate of addition of the feed medium was automatically adjusted by a peristaltic pump so as to be within the range. About 24 hours after starting the main culture, feed medium
L was added to complete the culture. The average yield of the culture broth was 7.2 g / L, and the coefficient of variation of 5 times was small, and the productivity was very stable.
【0029】[0029]
【実施例5】実施例1のフィード培地を、肉エキス15
%水溶液に置き換えて、実施例1と同様に酸素消費速度
を5〜8 m mol 02 /L・hr.の範囲になる
ように、主培養開始後10時間目から、該フィード培地
をペリスタポンプにより添加速度を自動調整し培養を行
った。主培養開始後24時間でフィード培地を約2L添
加し、培養を終了した。高収量であり、非常に安定した
生産性を示した。Example 5 The feed medium of Example 1 was used as meat extract 15
% Aqueous solution, and the oxygen consumption rate was 5 to 8 mmol mol 0 2 / L · hr. From the 10th hour after the start of the main culture, the rate of addition of the feed medium was automatically adjusted by a peristaltic pump so as to be within the range. About 24 hours after the start of the main culture, about 2 L of the feed medium was added to complete the culture. The yield was high and the productivity was very stable.
【0030】[0030]
【実施例6】実施例1のフィード培地を、粉末酵母10
%水懸濁液に置き換えて、実施例1と同様に酸素消費速
度を5〜8 m mol 02 /L・hr.の範囲にな
るように、主培養開始後10時間目から、該フィード培
地をペリスタポンプにより添加速度を自動調整し培養を
行った。主培養開始後24時間でフィード培地を約2L
添加し、培養を終了した。高収量であり、非常に安定し
た生産性を示した。Example 6 The feed medium of Example 1 was mixed with powdered yeast 10
% Aqueous suspension, and the oxygen consumption rate was 5 to 8 mmol mol 0 2 / L · hr. From the 10th hour after the start of the main culture, the rate of addition of the feed medium was automatically adjusted by a peristaltic pump so as to be within the range. Approximately 2 L of feed medium 24 hours after the start of main culture
And the culture was completed. The yield was high and the productivity was very stable.
【0031】[0031]
【発明の効果】本発明によれば、ヒアルロン酸を極めて
安定に且つ高収量に生産供給する事が出来る。INDUSTRIAL APPLICABILITY According to the present invention, hyaluronic acid can be produced and supplied in an extremely stable and high yield.
Claims (1)
ン酸を生成する能力を有する微生物を通気攪拌培養する
に際し、培養槽のガス供給口とガス排気口の酸素含量を
測定し、該微生物の酸素消費速度を5〜8 m mol
02 /L・hr.に制御することを特徴とするヒアル
ロン酸の製造法。1. When a microorganism belonging to the genus Streptococcus and having the ability to produce hyaluronic acid is subjected to aeration stirring culture, the oxygen content at the gas supply port and the gas exhaust port of the culture tank is measured to determine the oxygen consumption rate of the microorganism. ~ 8 mmol
0 2 / L · hr. A method for producing hyaluronic acid, characterized in that
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25115592A JPH0698787A (en) | 1992-09-21 | 1992-09-21 | Production of hyaluronic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25115592A JPH0698787A (en) | 1992-09-21 | 1992-09-21 | Production of hyaluronic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0698787A true JPH0698787A (en) | 1994-04-12 |
Family
ID=17218497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25115592A Withdrawn JPH0698787A (en) | 1992-09-21 | 1992-09-21 | Production of hyaluronic acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0698787A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009028032A (en) * | 2007-07-03 | 2009-02-12 | Mitsubishi Rayon Co Ltd | Method for producing hyaluronic acid |
| JP2014094012A (en) * | 2007-12-20 | 2014-05-22 | Novartis Ag | Fermentation process for cultivating streptococcus and purification process for obtaining capsular polysaccharide (cp) derived from streptococcus |
-
1992
- 1992-09-21 JP JP25115592A patent/JPH0698787A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009028032A (en) * | 2007-07-03 | 2009-02-12 | Mitsubishi Rayon Co Ltd | Method for producing hyaluronic acid |
| JP2014094012A (en) * | 2007-12-20 | 2014-05-22 | Novartis Ag | Fermentation process for cultivating streptococcus and purification process for obtaining capsular polysaccharide (cp) derived from streptococcus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4567140A (en) | Microbial polysaccharides, process for their preparation, microorganisms suitable for this and use of the polysaccharides | |
| US4929550A (en) | Process for the production of microbial cellulose | |
| US4400467A (en) | Process of using xanthomonas campestris NRRL B-12075 and NRRL B-12074 for making heteropolysaccharide | |
| JP3555957B2 (en) | Klebsiella pneumoniae, subsp. Novel strain of Pneumoniae and method for producing L-fucose-containing polysaccharide | |
| US4355106A (en) | Continuous process for the production of gelable exopolysaccharide | |
| US5514792A (en) | Chemically modified succinoglycans and industrial compositions comprised thereof | |
| US4696900A (en) | Production of bacterial polysaccharides | |
| Marqués et al. | Production and rheological properties of the extracellular polysaccharide synthesized by Pseudomonas sp. strain EPS-5028 | |
| JPH02234689A (en) | Production of hyaluronic acid | |
| JP4151092B2 (en) | Method for producing oligohyaluronic acid or a salt thereof | |
| US3856625A (en) | Process for the production of polysaccharide | |
| JPS6394988A (en) | Production of hyaluronic acid | |
| US3433708A (en) | Process for producing a polysaccharide | |
| US4282321A (en) | Fermentation process for production of xanthan | |
| JPH0698787A (en) | Production of hyaluronic acid | |
| US4377637A (en) | Method for producing a low viscosity xanthan gum | |
| CN111778303B (en) | Method for degrading hyaluronic acid or salt thereof by enzyme | |
| US3957579A (en) | Method for preparing d-tartaric acid | |
| JP3632197B2 (en) | Method for producing high molecular weight hyaluronic acid or salt thereof | |
| JPS6328398A (en) | Production of hyaluronic acid | |
| US4301247A (en) | Method for improving xanthan yield | |
| JP3973312B2 (en) | Method for producing hyaluronic acid by fermentation | |
| JPS62215397A (en) | Production of hyaluronic acid | |
| EP0195773B1 (en) | Continuous production of bacterial polysaccharide | |
| JPH06253877A (en) | Production of cellulosic substance by microorganism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 19991130 |